SPIE Membership Get updates from SPIE Newsroom
  • Newsroom Home
  • Astronomy
  • Biomedical Optics & Medical Imaging
  • Defense & Security
  • Electronic Imaging & Signal Processing
  • Illumination & Displays
  • Lasers & Sources
  • Micro/Nano Lithography
  • Nanotechnology
  • Optical Design & Engineering
  • Optoelectronics & Communications
  • Remote Sensing
  • Sensing & Measurement
  • Solar & Alternative Energy
  • Sign up for Newsroom E-Alerts
SPIE Photonics Europe 2018 | Register Today!

2018 SPIE Optics + Photonics | Register Today




Print PageEmail Page

Biomedical Optics & Medical Imaging

Fraxel re:pair laser for CO2 laser skin resurfacing

Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments, announces the launch of its Fraxel re:pairlaser system to the dermatology community.

The Fraxel re:pair laser system, the result of two years of clinical research, represents a new category in skin rejuvenation: Ablative Fractional Resurfacing (AFR™) treatment. It is the only device on the market that has received FDA clearance specifically for skin resurfacing with a fractional mode of delivery.

The Fraxel re:pair laser is the industry' s only minimally invasive, ablative fractional laser system that delivers a full spectrum of aesthetic treatment from Fractional MicroDermAblation™ (FMDA™) treatment to Fractional Deep Dermal Ablation™ (FDDA™) treatment. It is the only ablative resurfacing device capable of being operated by a single clinician, because of its built-in smoke evacuation system, and capable of treating at depths from 300 micrometers (µm) to 1.6 mm into the dermis, all in a single hand piece.

Reliant Technologies is currently studying the Fraxel re:pair laser as a treatment for acne scars and atrophic scars. More than 500 subjects are being evaluated in ongoing clinical trials with the Fraxel re:pair laser.